Biotech - Press Releases

Date	Title	Company
06-Jul-2020	BCI Pharma appoints Didier Malherbe as chairman of board of directors	Andrew Lloyd Associates
06-Jul-2020	Medivir and SciLifeLab Enter Collaboration on Potential SARS CoV-2 Inhibitors	Medivir
03-Jul-2020	Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure	Biophytis SA
03-Jul-2020	Hansa Biopharma announces exclusive agreement with Sarepta Therapeutics to develop and promote imlifidase as pre-treatment ahead of gene therapy in select indications	Hansa Biopharma
03-Jul-2020	RDIF and ChemRar announce increased production of Avifavir for treatment of coronavirus and begin export deliveries	The Russian Direct Investment Fund
03-Jul-2020	osteolabs GmbH Provides Further Validation for Use of OsteoTest in Osteoporosis and Early-Stage Kidney Malfunction	osteolabs GmbH
03-Jul-2020	Boehringer Ingelheim announces new partnership with STEM Learning to boost STEM education in Berkshire schools	Boehringer Ingelheim
03-Jul-2020	Major Shareholder Announcement	Genmab
03-Jul-2020	Biophytis announces a € 6.1 million capital increase through private placement	Biophytis SA
03-Jul-2020	Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation	Acacia Pharma
03-Jul-2020	Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients	Sanofi
03-Jul-2020	Consilium Strategic Communications Advises Hyloris Pharmaceuticals on its Successful Initial Public Offering	Consilium Strategic Communications
03-Jul-2020	Biophytis Announces a € 6.1 Million Capital Increase Through Private Placement	Biophytis SA
02-Jul-2020	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Akebia Therapeutics
02-Jul-2020	PURA First Step Toward New Cannabis Cultivation Spinoff Deal and Corresponding Dividend Coming Next Week	Puration Inc.
02-Jul-2020	Liminal BioSciences Joins CoVIg Plasma Alliance to Contribute to Development of Potential New COVID-19 Therapy	Liminal BioSciences Inc.
02-Jul-2020	inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations	inHEART
02-Jul-2020	(Covid-19) Impact Analysis : Ciprofloxacin Hcl Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2026	Qurate Business Intelligence
02-Jul-2020	Affinity discovers potent SARS-CoV-2 antibodies	Affinity Biosciences
01-Jul-2020	MetVital, Inc. Announces FDA Fast Track Designation of Anhydrous Enol-Oxaloacetate (AEO) for the Treatment of Patients with Newly Diagnosed Glioblastoma Multiforme	MetVital, Inc.